Paydirt
HS
Insider

Hong Fang Song

Director

Hong Fang Song (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in CG Oncology, Inc. (CGON). The largest single filing was $19.6M of CGON (700,000 sh × $28.00, as filed), executed Dec 16 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$22.4M
shares × price, as filed
Last traded
Sep 3 2025
Filed Sep 4 2025

Median ADV $76.8M across their filed names

Open performance
Volume by month
$19.6M$9.8M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2024 · sells $19.6MSep 2025 · sells $2.8M
Buys $0 Sells $22.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 24 months

Most traded names
CGON CG Oncology, Inc. CGON · 0 buys · 2 sells 2 filings
Recent filings
CGONSALE CG Oncology, Inc. View filing → $2.8M
99,800 sh across 2 lots
Exec Sep 3 2025
Filed Sep 4 2025 · 5:30 PM ET
CGONSALE CG Oncology, Inc. View filing → $19.6M
700,000 sh × $28.00
Exec Dec 16 2024
Filed Dec 17 2024 · 5:30 PM ET